Thrombogenics N.V. | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
172,361.00
127,076.00
101,385.00
80,068.00
115,730.00
85,127
Total Accounts Receivable
12,188.00
14,868.00
8,240.00
7,664.00
5,910.00
2,739
Inventories
6,111.00
7,224.00
6,498.00
2,614.00
2,204.00
1,036
Other Current Assets
974.00
-
570.00
1,093.00
439.00
2,187
Total Current Assets
191,634.00
149,168.00
116,693.00
91,439.00
124,283.00
91,089
Net Property, Plant & Equipment
3,634.00
2,911.00
2,088.00
1,743.00
991.00
614
Total Investments and Advances
-
-
235.00
202.00
126.00
-
Long-Term Note Receivable
2,307.00
2,061.00
-
-
-
-
Intangible Assets
71,795.00
64,974.00
58,285.00
25,902.00
23,603.00
20,450
Other Assets
1,784.00
1,600.00
1,645.00
2,350.00
1,434.00
2,711
Total Assets
271,154.00
220,714.00
178,946.00
121,636.00
150,437.00
114,864
Accounts Payable
10,352.00
7,369.00
4,128.00
5,941.00
3,298.00
Other Current Liabilities
2,030.00
5,333.00
4,803.00
5,836.00
13,782.00
Total Current Liabilities
12,382.00
12,702.00
8,931.00
11,777.00
17,080.00
Total Liabilities
12,382.00
12,702.00
8,931.00
11,777.00
17,080.00
Common Equity (Total)
258,772.00
208,012.00
169,938.00
109,816.00
132,630.00
Total Shareholders' Equity
258,772.00
208,012.00
169,938.00
109,816.00
132,630.00
Total Equity
258,772.00
208,012.00
170,015.00
109,859.00
133,357.00
Liabilities & Shareholders' Equity
271,154.00
220,714.00
178,946.00
121,636.00
150,437.00
Accumulated Minority Interest
-
-
77.00
43.00
727.00
About Thrombogenics
View Profile
